Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial.

Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI; Postmenopausal Estrogen/Progestin Intervention Trial.

J Clin Endocrinol Metab. 2003 Apr;88(4):1646-52.

PMID:
12679451
2.

Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.

Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM.

Metabolism. 1997 Jan;46(1):5-9.

PMID:
9005961
3.

Total but not bioavailable testosterone is a predictor of central adiposity in postmenopausal women.

Goodman-Gruen D, Barrett-Connor E.

Int J Obes Relat Metab Disord. 1995 May;19(5):293-8.

PMID:
7647819
4.

Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.

Crandall C, Palla S, Reboussin B, Hu P, Barrett-Connor E, Reuben D, Greendale G.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):14-23.

PMID:
16417414
5.

Sex hormone levels and risk of breast cancer with estrogen plus progestin.

Farhat GN, Parimi N, Chlebowski RT, Manson JE, Anderson G, Huang AJ, Vittinghoff E, Lee JS, Lacroix AZ, Cauley JA, Jackson R, Grady D, Lane DS, Phillips L, Simon MS, Cummings SR.

J Natl Cancer Inst. 2013 Oct 2;105(19):1496-503. doi: 10.1093/jnci/djt243. Epub 2013 Sep 16.

6.

Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women.

Lambrinoudaki I, Christodoulakos G, Rizos D, Economou E, Argeitis J, Vlachou S, Creatsa M, Kouskouni E, Botsis D.

Eur J Endocrinol. 2006 Jun;154(6):907-16.

7.

The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women.

Kalyani RR, Franco M, Dobs AS, Ouyang P, Vaidya D, Bertoni A, Gapstur SM, Golden SH.

J Clin Endocrinol Metab. 2009 Nov;94(11):4127-35. doi: 10.1210/jc.2009-0910. Epub 2009 Sep 29.

8.

Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.

Maturitas. 2005 Apr 11;50(4):321-30.

PMID:
15780533
9.

Sex hormone levels and risk of cardiovascular events in postmenopausal women.

Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR, Buring JE.

Circulation. 2003 Oct 7;108(14):1688-93. Epub 2003 Sep 15.

10.

Endogenous sex hormones and glucose tolerance status in postmenopausal women.

Golden SH, Dobs AS, Vaidya D, Szklo M, Gapstur S, Kopp P, Liu K, Ouyang P.

J Clin Endocrinol Metab. 2007 Apr;92(4):1289-95. Epub 2007 Jan 23.

PMID:
17244779
11.

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.

PMID:
15840882
12.

Both total testosterone and sex hormone-binding globulin are independent risk factors for metabolic syndrome: results from Fangchenggang Area Male Health and Examination Survey in China.

Zhang J, Huang X, Liao M, Gao Y, Tan A, Yang X, Zhang H, Mo L, Zhang Y, Lu Z, Wu C, Hu Y, Mo Z.

Diabetes Metab Res Rev. 2013 Jul;29(5):391-7. doi: 10.1002/dmrr.2405.

PMID:
23463406
13.

Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.

Wang L, Szklo M, Folsom AR, Cook NR, Gapstur SM, Ouyang P.

Atherosclerosis. 2012 Sep;224(1):228-34. doi: 10.1016/j.atherosclerosis.2012.07.005. Epub 2012 Jul 20.

14.

The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women.

Davis SR, Robinson PJ, Moufarege A, Bell RJ.

Clin Endocrinol (Oxf). 2012 Oct;77(4):541-7. doi: 10.1111/j.1365-2265.2011.04301.x.

PMID:
22106826
15.

Postmenopausal sex hormones in relation to body fat distribution.

Liedtke S, Schmidt ME, Vrieling A, Lukanova A, Becker S, Kaaks R, Zaineddin AK, Buck K, Benner A, Chang-Claude J, Steindorf K.

Obesity (Silver Spring). 2012 May;20(5):1088-95. doi: 10.1038/oby.2011.383. Epub 2012 Jan 12.

16.

Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones.

Laughlin GA, Barrett-Connor E, May S.

Int J Obes (Lond). 2007 Mar;31(3):457-65. Epub 2006 Jul 4.

PMID:
16819528
17.

Associations of body fat distribution, circulating sex hormones, and bone density in postmenopausal women.

Heiss CJ, Sanborn CF, Nichols DL, Bonnick SL, Alford BB.

J Clin Endocrinol Metab. 1995 May;80(5):1591-6.

PMID:
7745005
18.

Endogenous sex hormones and their associations with cardiovascular risk factors in post-menopausal women.

Güdücü N, Görmüş U, Kutay SS, Kavak ZN, Telatar B.

J Endocrinol Invest. 2013 Sep;36(8):588-92. doi: 10.3275/8881. Epub 2013 Feb 27.

PMID:
23448998
19.

Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women.

Worsley R, Robinson PJ, Bell RJ, Moufarege A, Davis SR.

Menopause. 2013 Jun;20(6):640-5. doi: 10.1097/GME.0b013e318279bd4a.

PMID:
23531683
20.

Supplemental Content

Support Center